Established in 2009 and headquartered in Chengdu High-tech district, Chengdu Easton Biopharmaceuticals Co., Ltd. is a Hi-tech pharmaceutical company, engaging in development, manufacture and distribution of commercial-scale Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). Our manufacturing facilities are fully compliant with EU-GMP and US-GMP standards.
Easton Biopharma has two manufacture sites and two sales companies. Formulation manufacturing site, located in Chengdu headquarter, has four Chinese cGMP-compliant production lines including Tablets, Capsules, Injection solutions and Lyophilization vials. API manufacturing site, located in Meishan, Sichuan Province, has ten CFDA approved APIs.
Easton Biopharma implements innovation-driven strategy for achieving sustainable development, with focusing on continuant improvement of R&D system. We are equipped with a scientific R&D platform including QC labs, R&D center and post-doctoral center. We aim to develop and produce new and generic drugs in the fields of Diabetics, Cardiovascular, Oncology, Anesthetic, Analgesics and Biopharmaceuticals.
Easton Biopharma has two manufacture sites and two sales companies. Formulation manufacturing site, located in Chengdu headquarter, has four Chinese cGMP-compliant production lines including Tablets, Capsules, Injection solutions and Lyophilization vials. API manufacturing site, located in Meishan, Sichuan Province, has ten CFDA approved APIs.
Easton Biopharma implements innovation-driven strategy for achieving sustainable development, with focusing on continuant improvement of R&D system. We are equipped with a scientific R&D platform including QC labs, R&D center and post-doctoral center. We aim to develop and produce new and generic drugs in the fields of Diabetics, Cardiovascular, Oncology, Anesthetic, Analgesics and Biopharmaceuticals.
